For a patient receiving intravenous piperacillin‑tazobactam for perforated diverticulitis, what oral antibiotic regimen should be used at discharge to complete a 14‑day course?

Oral Antibiotic Regimen for Discharge After IV Piperacillin-Tazobactam for Perforated Diverticulitis

For discharge after IV piperacillin-tazobactam treatment of perforated diverticulitis, transition to oral amoxicillin-clavulanate 875/125 mg twice daily to complete a total 14-day course of antibiotics. 1

Primary Oral Regimen

• Amoxicillin-clavulanate 875/125 mg orally twice daily is the first-line oral option for completing treatment of complicated intra-abdominal infections including perforated diverticulitis 1, 2
• This provides continued coverage against gram-negative aerobes (E. coli) and anaerobes (Bacteroides fragilis) that are the predominant pathogens in colonic perforations 1
• The total duration of antibiotic therapy (IV plus oral) should be 14 days for complicated diverticulitis with perforation 1, 2

Alternative Oral Regimens

If the patient has a beta-lactam allergy, use one of these alternatives:

• Ciprofloxacin 500-750 mg orally twice daily PLUS metronidazole 500 mg orally three times daily 1
• Levofloxacin 750 mg orally once daily PLUS metronidazole 500 mg orally three times daily 1
• Moxifloxacin 400 mg orally once daily (provides both gram-negative and anaerobic coverage as monotherapy) 1

Transition Timing

• Transition from IV to oral antibiotics when the patient demonstrates clinical improvement: afebrile for 24 hours, tolerating oral intake, decreasing leukocytosis, and improving abdominal examination 1, 2
• The FDA label for piperacillin-tazobactam indicates typical treatment duration of 7-10 days for intra-abdominal infections, but complicated cases with perforation warrant the longer 14-day course 3

Important Caveats

• Immunocompromised patients (those on steroids, chemotherapy, or transplant recipients) may require longer courses (10-14 days minimum) and closer monitoring 1, 2
• Patients who received oral antibiotics in the 7 days prior to admission have increased risk of treatment failure and should be monitored more closely 4
• If cultures grew ESBL-producing organisms or other resistant pathogens, antibiotic selection must be guided by susceptibility results rather than empiric regimens 1
• Recent evidence shows ceftriaxone plus metronidazole is non-inferior to piperacillin-tazobactam for complicated diverticulitis, but this combination requires IV administration and is not suitable for oral discharge therapy 4